Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAA Furosemide Trial: Adjunctive Acetazolamide in ICU Patients Receiving Furosemide
jRCTs031250404Recruiting
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised trial of acetazolamide in hypervolemia, critical illness and metabolic alkalosis (2 arms). Primary endpoint: Base excess over 48 hours. Started Oct 2025; status: recruiting.
02
Drugs
acetazolamide
03
Conditions
hypervolemiacritical illnessmetabolic alkalosis
Beyond the preview
Go deeper on jRCTs031250404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250404.